Related Experiment Video
Updated: Jun 12, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via
Anne Baudry1, Juliette Bitard, Sophie Mouillet-Richard
1Cellules Souches, Signalisation et Prions, INSERM U747, Université Paris Descartes, Paris, France.
Abstract:
In previous studies, we observed that mice knocked out for the serotonin-2B receptor (5-HT(2B)R) show defects in bone homeostasis. The present work focuses on the downstream targets relaying the anabolic function of this receptor in osteoblasts. A functional link between the 5-HT(2B)R and the activity of the tissue-nonspecific alkaline phosphatase (TNAP) is established using the C1 osteoprogenitor cell line. During C1 osteogenic differentiation, both 5-HT(2B)R and TNAP mRNA translations are delayed with respect to extracellular matrix deposition. Once the receptor is expressed, it constitutively controls TNAP activity at a post-translational level along the overall period of mineral deposition. Indeed, pharmacological inhibition of the 5-HT(2B)R intrinsic activity or shRNA-mediated 5-HT(2B)R knockdown prevents TNAP activation, but not its mRNA translation. In contrast, agonist stimulation of the receptor further increases TNAP activity during the initial mineralization phase. Building upon our previous observations that the 5-HT(2B)R couples with the phospholipase A2 pathway and prostaglandin production at the beginning of mineral deposition, we show that the 5-HT(2B)R controls leukotriene synthesis via phospholipase A2 at the terminal stages of C1 differentiation. These two 5-HT(2B)R-dependent eicosanoid productions delineate distinct time windows of TNAP regulation during the osteogenic program. Finally, prostaglandins or leukotrienes are shown to relay the post-translational activation of TNAP via stimulation of the phosphatidylinositol-specific phospholipase C. In agreement with the above findings, primary calvarial osteoblasts from 5-HT(2B)R-null mice exhibit defects in TNAP activity.
Insights
The serotonin-2B receptor (5-HT2BR) regulates bone health by controlling tissue-nonspecific alkaline phosphatase (TNAP) activity. This receptor influences TNAP post-translationally through prostaglandins and leukotrienes during osteoblast differentiation.
Area of Science:
- Bone biology
- Cell signaling
- Receptor pharmacology
Background:
- The serotonin-2B receptor (5-HT2BR) plays a role in maintaining bone homeostasis.
- Previous studies indicated defects in bone homeostasis in mice lacking 5-HT2BR.
- The downstream molecular mechanisms of 5-HT2BR's anabolic function in osteoblasts require elucidation.
Purpose of the Study:
- To identify downstream targets of the serotonin-2B receptor (5-HT2BR) involved in its anabolic function in osteoblasts.
- To establish a functional link between 5-HT2BR and tissue-nonspecific alkaline phosphatase (TNAP) activity during osteogenic differentiation.
- To investigate the role of eicosanoids in mediating 5-HT2BR's regulation of TNAP.
Main Methods:
- Utilized the C1 osteoprogenitor cell line for in vitro studies.
- Employed pharmacological inhibition and shRNA-mediated knockdown to assess 5-HT2BR function.
- Measured mRNA translation, protein activity, and eicosanoid synthesis (prostaglandins, leukotrienes).
- Investigated downstream signaling pathways including phospholipase A2 and phosphatidylinositol-specific phospholipase C.
Main Results:
- 5-HT2BR and TNAP mRNA translation are delayed relative to extracellular matrix deposition during C1 osteogenic differentiation.
- 5-HT2BR constitutively controls TNAP activity post-translationally, independent of its mRNA translation.
- Pharmacological inhibition or knockdown of 5-HT2BR prevents TNAP activation.
- Agonist stimulation of 5-HT2BR enhances TNAP activity during early mineralization.
- 5-HT2BR regulates leukotriene synthesis via phospholipase A2 at later differentiation stages.
- Prostaglandins and leukotrienes mediate post-translational TNAP activation via phosphatidylinositol-specific phospholipase C.
- Primary calvarial osteoblasts from 5-HT2BR-null mice show impaired TNAP activity.
Conclusions:
- The serotonin-2B receptor (5-HT2BR) is a key regulator of tissue-nonspecific alkaline phosphatase (TNAP) activity in osteoblasts.
- 5-HT2BR exerts post-translational control over TNAP activity through distinct prostaglandin and leukotriene signaling pathways during osteogenesis.
- These findings reveal novel molecular mechanisms by which 5-HT2BR influences bone anabolic function.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
TGF - β Signaling Pathway
Amplifying Signals via Second Messengers
